AI assistant
Twist Bioscience Corp — Director's Dealing 2019
Feb 5, 2019
31873_dirs_2019-02-05_6be0321b-9cc7-410d-a6c6-9d2b64344e7a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-02-04
Reporting Person: Kunz Martin (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-04 | Common Stock | A | 12936 | $0.00 | Acquired | 12936 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-04 | Employee Stock Option (right to buy) | $23.19 | A | 60371 | Acquired | 2029-02-03 | Common Stock (60371) | Direct |
Footnotes
F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on February 4, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2: 25% of the shares subject to the option vest and become exercisable on February 4, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.